11 unchanged sentences
March 10, 2020
−Removed: Fourth Amendment to Loan and Security Agreement, dated April 27, 2020
−Removed: Filed herewith
Open Market Sale Agreement SM , dated as of July 7, 2020
−Removed: Amended and Restated 2019 Stock Option and Incentive Plan and Forms thereunder
+Added: Agreement and Plan of Merger, dated as of October 5, 2020, by and among BridgeBio Pharma, Inc., Eidos Therapeutics, Inc., Globe Merger Sub I, Inc.
+Added: and Globe Merger Sub II, Inc.
+Added: O ctober 6, 2020
+Added: Amended and Restated 2019 Employee Stock Purchase Plan, effective December 12, 2019
+Added: Filed herewith
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
20 unchanged sentences
Filed herewith
−Removed: Certain confidential portions (indicated by brackets and asterisks) have been omitted from this exhibit in accordance with the rules of the Securities and Exchange Commission.
This certification will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section.
3 unchanged sentences
BridgeBio Pharma, Inc.
−Removed: August 11, 2020
+Added: November 5, 2020
/s/ Neil Kumar
2 unchanged sentences
(Principal Executive Officer)
−Removed: August 11, 2020
+Added: November 5, 2020
/s/ Brian Stephenson
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.